dotMD.com
Heart & Cardiovascular Disease • ICD-10-CM R00.1

Arrhythmia

Also known as: Irregular heartbeat, Bradycardia, Disorder, Syndrome, Diseases

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM R00.1 • 8 Linked .gov / PubMed Citations • Governance: Dr. Marcus Thorne, MD, FACC (NPI #1184629314)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Arrhythmia Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Arrhythmia

3 of 3 Free Questions Remaining

What Is Arrhythmia?

What is an arrhythmia? An arrhythmia is a problem with the rate or rhythm of your heartbeat. Your heart beats too quickly, too slowly, or with an irregular pattern. Changes in the electrical signals that control your heartbeat cause arrhythmias. When your heart beats faster than normal, it's called tachycardia . When your heart beats too slowly, it's called bradycardia . When the signal to beat comes too early, it's called a premature or extra heartbeat . It may feel like your heart skipped a beat. There are many types of arrhythmias. Arrhythmias may affect the upper or lower chamber of your heart.

Pathophysiology, Underlying Causes & Clinical Presentation

Biological expression of Arrhythmia (R00.1, Heart & Vascular) reflects structural ventricular wall in Arrhythmia (R00.1: stress). Cross-referenced with NIH MeSH (Arrhythmias, Cardiac), longitudinal control is benchmarked via Left Ventricular Ejection in Arrhythmia (R00.1: Fraction (LVEF)).

Common Symptoms & Clinical Signs

  • • When your heart beats faster than normal, it's called tachycardia
  • • When your heart beats too slowly, it's called bradycardia
  • • Presentation of Arrhythmia (R00.1): palpitations, skipped beats, in Arrhythmia (R00.1: or irregular resting)
  • • Secondary Arrhythmia clinical sign: unexplained lower-extremity ankle in Arrhythmia (R00.1: edema or rapid)

Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗

Arrhythmia Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code R00.1 WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub Heart & Cardiovascular Disease NIH MedlinePlus Health Topics
Diagnostic / Lab Marker: Left Ventricular Ejection in Arrhythmia (R00.1: Fraction (LVEF)) 55% – 70% (R00.1) Clinical Reference Target Range
Diagnostic / Lab Marker: NT-proBNP [Arrhythmia R00.1] < 100 pg/mL (R00.1) Clinical Reference Target Range
Diagnostic / Lab Marker: High-Sensitivity Troponin I [Arrhythmia R00.1] < 14 ng/L (R00.1) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Arrhythmia

Check Drug Interactions →

Treatment selection for Arrhythmia depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Arrhythmia)

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
New Insights on Causes of heart and blood vessel Hospitalization and Death in Patients With: What a 264-Participant Study Found

These data provide further insight into CV disease progression in patients with ATTR-CM, with HF the most common adjudicated cause of CV-related hospitalization or death in ATTR-ACT.

The American journal of cardiology • 2021-06-01 • Phase III Randomized Trial
N = 264 93/100 PMID 33667442 ↗
Can This Approach Help? Inside the Latest Research on Vasomotor hot flashes and heart rate variability: a compared against a dummy pill

Oral estrogen, especially when combined with MPA, may have adverse effects on HRV in women with and without hot flashes, whereas transdermal estradiol showed no such effects.

Menopause (New York, N.Y.) • 2012-01-15 • Randomized Controlled Trial
Multi-cohort 88/100 PMID 21934534 ↗
Can This Approach Help? Inside the Latest Research on Slow heart rate and Other Arrhythmias in Patients With Hepatorenal Syndrome-Acute

In a pooled analysis, slow heart rate was observed in 6% of terlipressin-treated patients but rarely required a dose interruption or reduction.

Alimentary pharmacology & therapeutics • 2025-12-15 • Phase III Randomized Trial
Multi-cohort 88/100 PMID 40704461 ↗
Can This Approach Help? Inside the Latest Research on Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase

Clinical evaluations showed no significant effects on QTcF or other electrocardiogram parameters at 7.1 mg/kg.

Clinical and translational science • 2025-02-15 • Phase III Randomized Trial
N = 29 88/100 PMID 39980062 ↗
Can This Approach Help? Inside the Latest Research on Vasomotor hot flashes and cardiac repolarization: a randomized compared against a

Hot flashes predict beneficial shortening in cardiac repolarization during OE, but not if MPA is combined with OE.

Menopause (New York, N.Y.) • 2017-12-15 • Randomized Controlled Trial
Multi-cohort 88/100 PMID 28697043 ↗
Zero-PHI Patient Support & Cohort Discussions

Arrhythmia Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Arrhythmia community threads and patient logs by age, biological sex, dosage, and treatment duration.

Female • 18-29 • Biomarker: Left Ventricular Ejection • Week 2722 helpful • 2 replies

Tracking Left Ventricular Ejection in Arrhythmia (R00.1: Fraction (LVEF)) every 12 weeks for Arrhythmia: what lab cadence worked best?

Pinned FDA/PubMed Clinical Context Note • Dr. Lin — AI PubMed Clinical Trial Lead

FDA/PubMed Clinical Context Note: Clinical guidelines across Heart & Cardiovascular Disease (Arrhythmia, ICD-10-CM R00.1) generally pair 8-to-12-week repeat biomarker verification (Left Ventricular Ejection in Arrhythmia (R00.1: Fraction (LVEF)): 55% – 70% (R00.1)) with symptom review so steady-state physiological response is captured accurately.

After being diagnosed with Arrhythmia (ICD-10 R00.1), my clinician and I set a goal around Left Ventricular Ejection in Arrhythmia (R00.1: Fraction (LVEF)) (55% – 70% (R00.1)) before escalating medication doses. For others managing heart & vascular markers, did quarterly bloodwork catch changes early enough without over-testing?

Male • 60+ • Week 24

12-week intervals worked really well for tracking Left Ventricular Ejection in Arrhythmia (R00.1: Fraction (LVEF)). Using the same morning fasting draw window each quarter eliminated day-to-day noise so my doctor could adjust cleanly.

Adult • 18-29 • Direct Lab Cash

Ordering Left Ventricular Ejection in Arrhythmia (R00.1: Fraction (LVEF)) alongside standard preventive labs prior to my follow-up visit saved an extra co-pay and kept our appointment focused on actual trend lines.

Related Conditions in Heart & Cardiovascular Disease